Non-Squamous Non-Small Cell Lung Cancer Recruiting Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03329911A Comparative Study of BAT1706 and EU AvastinĀ® in Patients With Advanced Non Squamous Non Small Cell Lung CancerTreatment
NCT02633189Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung CancerTreatment